Format: Symposium

1-2 of 2 Activities
Title
Availability
Format
Credits
Launch Date
Buttons

Livestream: MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-world Applications in NF1-PN Management

In this CEC Oncology livestream, case-based symposium, expert faculty will discuss diagnosis and disease challenges over a person’s lifespan; explore the integration of MEK inhibitors in the management of NF1-associated PNs in pediatric patients; and consider comprehensive interprofessional care plans that include disease monitoring, toxicity management, and individualizing disease treatment across the patient’s lifespan.

1
05/08/2025 at 12:15 PM EST

Christopher Moertel, MD

Christopher Moertel, MD

Angela Hirbe, MD, PhD

Angela Hirbe, MD, PhD

Live
Symposium
1
05/08/2025 at 12:15 PM EST

MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-world Applications in NF1-PN Management

In this CEC Oncology live, case-based symposium, expert faculty will discuss diagnosis and disease challenges over a person’s lifespan; explore the integration of MEK inhibitors in the management of NF1-associated PNs in pediatric patients; and consider comprehensive interprofessional care plans that include disease monitoring, toxicity management, and individualizing disease treatment across the patient’s lifespan.

1
05/08/2025 at 12:15 PM EST

Christopher Moertel, MD

Christopher Moertel, MD

Angela Hirbe, MD, PhD

Angela Hirbe, MD, PhD